Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2014 ∙ Fortanier, A. C. Venekamp, R. P. Boonacker, C. W. Hak, E. Schilder, A. G. Sanders, E. A. Damoiseaux, R. A.

Pneumococcal conjugate vaccines for preventing otitis media

  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2014 ∙ Weil-Olivier, C. Millier, A. Toumi, M. Trichard, M.

Population access to rotavirus vaccination in industrialized countries: lessons learnt from current experience

  • All age groups
  • Rotavirus
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2014 ∙ Martin, S. Lopez, A. L. Bellos, A. Deen, J. Ali, M. Alberti, K. Anh, D. D. Costa, A. Grais, R. F. Legros, D. Luquero, F. J. Ghai, M. B. Perea, W. Sack, D. A.

Post-licensure deployment of oral cholera vaccines: a systematic review

  • All age groups
  • Cholera
  • Coverage
  • Economic aspects
  • Logistics
Methodological quality (AMSTAR 2):
Not applicable
2014 ∙ Sullivan, S. G. Feng, S. Cowling, B. J.

Potential of the test-negative design for measuring influenza vaccine effectiveness: A systematic review

  • All age groups
  • Pregnant women
  • Healthcare workers
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2014 ∙ Mangtani, P. Abubakar, I. Ariti, C. Beynon, R. Pimpin, L. Fine, P. E. M. Rodrigues, L. C. Smith, P. G. Lipman, M. Whiting, P. F. Sterne, J. A.

Protection by BCG vaccine against tuberculosis: A systematic review of randomized controlled trials

  • All age groups
  • Tuberculosis
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2014 ∙ Maglione, M. A. Das, L. Raaen, L. Smith, A. Chari, R. Newberry, S. Shanman, R. Perry, T. Goetz, M. B. Gidengil, C.

Safety of vaccines used for routine immunization of US children: A systematic review

  • Americas
  • United States of America
  • Newborn
  • Children
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2014 ∙ da Costa, V. G. Marques-Silva, A. C. Floriano, V. G. Moreli, M. L.

Safety, immunogenicity and efficacy of a recombinant tetravalent dengue vaccine: A meta-analysis of randomized trials

  • Children
  • Adults
  • Dengue
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2014 ∙ Gonçalves, A. K. Cobucci, R. N. Rodrigues, H. M. de Melo, A. G. Giraldo, P. C.

Safety, tolerability and side effects of human papillomavirus vaccines: a systematic quantitative review

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2014 ∙ Rambout, L. Tashkandi, M. Hopkins, L. Tricco, A. C.

Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: A systematic review

  • Americas
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2014 ∙ Miltz, A. Price, H. Shahmanesh, M. Copas, A. Gilson, R.

Systematic review and meta-analysis of L1-VLP-based human papillomavirus vaccine efficacy against anogenital pre-cancer in women with evidence of prior HPV exposure

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...